English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack

Henderson, D., Ogilvie, L. A., Hoyle, N., Keilholz, U., Lange, B., Lehrach, H., et al. (2014). Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack. Biotechnology Journal, 9(9), 1104-1114. doi:10.1002/biot.201400109.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-0025-B508-8 Version Permalink: http://hdl.handle.net/11858/00-001M-0000-0025-B50E-B
Genre: Journal Article

Files

show Files
hide Files
:
Henderson.pdf (Publisher version), 2MB
Name:
Henderson.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
© 2014 John Wiley & Sons, Inc.
License:
-

Locators

show
hide
Description:
-

Creators

show
hide
 Creators:
Henderson, D., Author
Ogilvie, L. A., Author
Hoyle, N., Author
Keilholz, U., Author
Lange, B., Author
Lehrach, H.1, Author              
OncoTrack, Consortium, Author
Yaspo, M. L.2, 3, Author              
Affiliations:
1Dept. of Vertebrate Genomics (Head: Hans Lehrach), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_1433550              
2Gene Regulation and Systems Biology of Cancer (Marie-Laure Yaspo), Independent Junior Research Groups (OWL), Max Planck Institute for Molecular Genetics, Max Planck Society, ou_2117287              
3OncoTrack Consortium, ou_persistent22              

Content

show
hide
Free keywords: Biomarkers; Colon cancer; Next-generation sequencing; Personalized medicine; Tumor heterogeneity
 Abstract: The post-genomic era promises to pave the way to a personalized understanding of disease processes, with technological and analytical advances helping to solve some of the world's health challenges. Despite extraordinary progress in our understanding of cancer pathogenesis, the disease remains one of the world's major medical problems. New therapies and diagnostic procedures to guide their clinical application are urgently required. OncoTrack, a consortium between industry and academia, supported by the Innovative Medicines Initiative, signifies a new era in personalized medicine, which synthesizes current technological advances in omics techniques, systems biology approaches, and mathematical modeling. A truly personalized molecular imprint of the tumor micro-environment and subsequent diagnostic and therapeutic insight is gained, with the ultimate goal of matching the "right" patient to the "right" drug and identifying predictive biomarkers for clinical application. This comprehensive mapping of the colon cancer molecular landscape in tandem with crucial, clinical functional annotation for systems biology analysis provides unprecedented insight and predictive power for colon cancer management. Overall, we show that major biotechnological developments in tandem with changes in clinical thinking have laid the foundations for the OncoTrack approach and the future clinical application of a truly personalized approach to colon cancer theranostics.

Details

show
hide
Language(s): eng - English
 Dates: 2014-07-292014-09
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: Peer
 Identifiers: DOI: 10.1002/biot.201400109
ISSN: 1860-7314 (Electronic)1860-6768 (Print)
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Biotechnology Journal
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: John Wiley & Sons, Inc.
Pages: - Volume / Issue: 9 (9) Sequence Number: - Start / End Page: 1104 - 1114 Identifier: -